Stocktoria
Zai Lab Ltd ZLAB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-28
Zai Lab Ltd financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $460.2M | $399.0M | $266.7M | $215.0M | $144.3M |
| R&D expense | $220.9M | $234.5M | $265.9M | $286.4M | $573.3M |
| SG&A expense | $277.6M | $298.7M | $281.6M | $259.0M | $218.8M |
| Operating income | -$229.4M | -$282.1M | -$366.6M | -$404.4M | -$700.1M |
| Interest expense | — | $2.3M | $0 | $0 | $0 |
| Income tax | -$2.9M | $0 | $0 | $0 | $0 |
| Net income | -$175.5M | -$257.1M | -$334.6M | -$443.3M | -$704.5M |
| EPS (diluted) | $-0.16 | $-0.26 | $-0.35 | $-0.46 | $-0.76 |
| Operating cash flow | -$150.8M | -$214.9M | -$198.2M | -$367.6M | -$549.2M |
| Free cash flow | -$158.9M | -$220.5M | -$205.4M | -$392.2M | -$567.5M |
| Cash & equivalents | $679.6M | $449.7M | $790.2M | $1.0B | $964.1M |
| Inventory | $74.7M | $39.9M | $44.8M | $31.6M | $19.0M |
| Total assets | $1.2B | $1.2B | $1.0B | $1.2B | $1.6B |
| Total liabilities | $456.9M | $344.9M | $240.2M | $174.5M | $230.0M |
| Shareholders' equity | $715.5M | $840.9M | $796.1M | $1.0B | $1.4B |
Source: SEC EDGAR filings · CIK 0001704292 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.